Beam stock forecast.

On average, analysts forecast that MSFT's EPS will be $11.13 for 2024, with the lowest EPS forecast at $10.83, and the highest EPS forecast at $11.55. On average, analysts forecast that MSFT's EPS will be $12.71 for 2025, with the lowest EPS forecast at $12.05, and the highest EPS forecast at $13.38.Get the latest Beam Therapeutics Inc (BEAM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …The average Beam Therapeutics stock price prediction forecasts a potential upside of 52.06% from the current BEAM share price of $27.95. What is BEAM's forecast return on equity (ROE) for 2023-2026? ( NASDAQ : BEAM ) forecast ROE is N/A , which is considered weak .Get the latest Infibeam Avenues Ltd (INFIBEAM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.BEAM Stock 12 Months Forecast. $43.44. (58.25% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Beam Therapeutics in the last 3 months. The average price target is $43.44 with a high forecast of $75.00 and a low forecast of $19.00. The average price target represents a 58.25% change from the last price of $27.45.

Find real-time UBER - Uber Technologies Inc stock quotes, company profile, news and forecasts from CNN Business.

See the latest Beam Therapeutics Inc stock price (BEAM:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Mar 5, 2023 · Following the upgrade, the consensus from 13 analysts covering Beam Therapeutics is for revenues of US$60m in 2023, implying a small 2.2% decline in sales compared to the last 12 months. Per-share ...

(See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage ...According to 9 stock analysts, the average 12-month stock price forecast for BEAM stock stock is $55.22, which predicts an increase of 93.14%. The lowest …Lead the world to clean mobility. We believe every person deserves access to safe, clean, reliable transportation. BEAM’s 100% sustainable EV charging solutions are the most rapidly deployed EV charging stations in the world. Fastest Deployed EV Charging In Action.BEAM Stock 12 Months Forecast. $43.44. (58.25% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Beam Therapeutics in the last 3 months. The average price target is $43.44 with a high forecast of $75.00 and a low forecast of $19.00. The average price target represents a 58.25% change from the last price of $27.45.Beam Therapeutics (BEAM-1.72%), COMPASS Pathways (CMPS-6.05%), and 908 Devices (MASS-2.56%) are three ARK Invest holdings with strong buy ratings and exceptionally high price targets from the ...

Find the latest Illumina, Inc. (ILMN) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...

Nov 29, 2023 · 3 Wall Street research analysts have issued 12-month price targets for Beam Global's shares. Their BEEM share price targets range from $25.00 to $25.00. On average, they anticipate the company's stock price to reach $25.00 in the next year. This suggests a possible upside of 315.3% from the stock's current price.

Stock Price Forecast. The 23 analysts offering 12-month price forecasts for Nokia Oyj have a median target of 4.39, with a high estimate of 7.60 and a low estimate of 3.49. The median estimate ...Wall Street Analysts Believe Beam Therapeutics Inc. (BEAM) Could Rally 81.29%: Here's is How to Trade The mean of analysts' price targets for Beam Therapeutics Inc. (BEAM) …Infibeam Avenues share price was Rs 20.15 as on 01 Dec, 2023, 03:59 PM IST. Infibeam Avenues share price was up by 0.74% based on previous share price of Rs 20.4. Infibeam Avenues share price trend: Last 1 Month: Infibeam Avenues share price moved up by 6.33%.The global welding market size was valued at USD 23.75 billion in 2022. The market is projected to grow from USD 24.73 billion in 2023 to USD 34.18 billion by 2030, exhibiting a CAGR of 4.7% during the forecast period. The welding industry has witnessed significant technological advancements in recent years, including the development of new ...Beam Therapeutics (BEAM-1.72%), COMPASS Pathways (CMPS-6.05%), and 908 Devices (MASS-2.56%) are three ARK Invest holdings with strong buy ratings and exceptionally high price targets from the ...Nov 30, 2023 · Beam Therapeutics Inc. (BEAM) Stock Price, Quote & News - Stock Analysis 29.67 +0.20 (0.68%) At close: Nov 24, 2023, 1:00 PM 30.22 +0.55 (1.85%) After-hours: Nov 24, 2023, 4:42 PM EST Overview Financials Statistics Profile Chart 1Y Max 0.68% ( 1D) About BEAM According to the issued ratings of 3 analysts in the last year, the consensus rating for Beam Global stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for BEEM. The average twelve-month price prediction for Beam Global is $25.00 with a high price target of $25.00 and a low price target of $25.00.

NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 151.68% change from the last price of $31.25. Beam has raised a $9.5 million Series A round. The company is working on a new web browser that completely rethinks the way you start a web session and browse the web. The startup is founded by Dom Leca and Sébastien Métrot. Dom Leca previo...Lumber increased 29.16 USD/1000 board feet or 5.87% since the beginning of 2023, according to trading on a contract for difference (CFD) that tracks the benchmark market for this commodity. Lumber - values, historical data, forecasts and news - updated on December of 2023.Jul 15, 2023 · Here are two such stocks that could generate monstrous returns on capital over the long run. Image source: Getty Images. 1. Beam Therapeutics. Beam Therapeutics ( BEAM -1.72%) is a biotechnology ... Oct 20, 2023 · According to the issued ratings of 11 analysts in the last year, the consensus rating for Beam Therapeutics stock is Hold based on the current 6 hold ratings and 5 buy ratings for BEAM. The average twelve-month price prediction for Beam Therapeutics is $53.64 with a high price target of $105.00 and a low price target of $20.00. Stock Price Forecast The 3 analysts offering 12-month price forecasts for Velo3D Inc have a median target of 2.00, with a high estimate of 2.10 and a low estimate of 1.48.

(See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage diagnostics company that provides care for transplant patients, from finding the right match to follow-on surveillance post-transplant.$-4.18 Market Cap $2.02 B Shares Outstanding 81.50 M Public Float 68.49 M Yield BEAM is not currently paying a regular dividend. Latest Dividend N/A Ex-Dividend Date N/A Short Interest (10/31/23)...

Meta Platforms Inc. () Stock Market info Recommendations: Buy or sell Meta Platforms stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Meta Platforms share forecasts, stock quote and buy / sell signals below.According to present data Meta Platforms's META shares and potentially its market environment have …SGMO Stock 12 Months Forecast. $2.20. (514.01% Upside) Based on 7 Wall Street analysts offering 12 month price targets for Sangamo Biosciences in the last 3 months. The average price target is $2.20 with a high forecast of $3.00 and a low forecast of $1.00. The average price target represents a 514.01% change from the last price of $0.36.Beam Global has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 3rd, 2024 based off last year's report dates. Learn more on BEEM's earnings history.Find the latest Altimmune, Inc. (ALT) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 2.00, with a high estimate of 8.00 and a low estimate of 0.50. The ...It’s difficult to put a positive spin on the current state of the stock market. While 2022’s action has seen moments of relief, for the most part, the trend has been resolutely downbeat, as reflected in the main indexes’ performances. All are down by at least double-digits; the tech-heavy NASDAQ’s 27% drop has been the most acute, while the …When is Beam Global's earnings date? Beam Global has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 3rd, 2024 based off last year's report dates. Learn more on BEEM's earnings history.Beam Therapeutics Inc. 27.50. Delayed Data. As of Nov 17. +2.71 / +10.93%. Today’s Change. 16.95. Today ||| 52-Week Range. 51.60.Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.Nov 22, 2023 · Beam Global Stock Forecast and Price Target. In recent months, notable analysts have provided yearlong price targets for Beam Global, with the average target coming in at $18.00. If it were to be achieved, this would result in a potential upside of approximately 222 percent from the most recent closing price in November, 2023.

In 2021, Vertex acquired the rights to 60% of the profits from sales of Crispr Therapeutics gene-editing therapy CTX001, now called exa-cel, for up to $1.1 billion, pending regulatory approval ...

(See BEAM stock forecast) CareDx, Inc . The next Wood-endorsed stock also belongs in the healthcare sector, although it offers a different value proposition. CareDx is a commercial-stage diagnostics company that provides care for transplant patients, from finding the right match to follow-on surveillance post-transplant.

Beam Therapeutics Inc. (BEAM) Stock Price, Quote & News - Stock Analysis 29.67 +0.20 (0.68%) At close: Nov 24, 2023, 1:00 PM 30.22 +0.55 (1.85%) After-hours: Nov 24, 2023, 4:42 PM EST Overview Financials Statistics Profile Chart 1Y Max 0.68% ( 1D) About BEAMSMM Review and Outlook of Copper and Aluminum Market in 2023-2024. Nov 29, 2023 17:35. UBS Base Metals Outlook 2024: Copper Will See A Supply Deficit, Aluminum Prices Will Be Higher Later In 2024, Lead And Zinc Will Be In Small Surplus ... LME, SHFE and COMEX copper stocks all hit multi-month low, with SHFE copper …“This call aims to develop an USPL that is ruggedized enough to begin testing in relevant Army environments,” it continued. The Army also began testing a prototype laser weapon for close-range air defense in May, the Defense Post reported.The high-energy laser will be able to locate, lock on, track and destroy aerial threats in just seconds.According to the issued ratings of 3 analysts in the last year, the consensus rating for Beam Global stock is Moderate Buy based on the current 1 hold rating and 2 buy ratings for BEEM. The average twelve-month price prediction for Beam Global is $25.00 with a high price target of $25.00 and a low price target of $25.00.SMM Review and Outlook of Copper and Aluminum Market in 2023-2024. Nov 29, 2023 17:35. UBS Base Metals Outlook 2024: Copper Will See A Supply Deficit, Aluminum Prices Will Be Higher Later In 2024, Lead And Zinc Will Be In Small Surplus ... LME, SHFE and COMEX copper stocks all hit multi-month low, with SHFE copper …The Biden administration is pushing hard to promote electric vehicles (EVs). From a $7.5 billion proThe current average BEAM price target, as estimated by these analysts, is $63.00. The predictions for the future BEAM stock price range from a low of $62.00 to a high of $66.00, highlighting the variability of market expectations for BEAM. Beam Therapeutics Inc. Watch NEW Set a price target alert After Hours Last Updated: Nov 28, 2023 4:20 p.m. EST Delayed quote $ 29.77 0.00 0.00% After Hours Volume: 14.9K Advanced Charting Volume:...Beam Global has risen higher in 7 of those 13 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.85%. Is Beam Global Stock Undervalued? The current Beam Global [ BEEM] share price is $6.02. The Score for BEEM is 49, which is 2% below its historic median score of 50, and infers higher risk than normal. BEEM stock forecast for 2023 – 2027. Last updated: November 25, 2023. BEEM. Beam Global. 5.85 D 4.84% (0.27) Are you interested in Beam Global stocks prediction? If yes, then on this page you will find useful information about the dynamics of the BEEM stock price in 2022-2027. Is BEEM a good long term stock? When should I …

Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.Find real-time EDIT - Editas Medicine Inc stock quotes, company profile, news and forecasts from CNN Business.Nov 29, 2023 · According to 3 analysts, the average rating for BEEM stock is "Strong Buy." The 12-month stock price forecast is $26.67, which is an increase of 343.02% from the latest price. Instagram:https://instagram. netflix.cometfcoins kennedy half dollar valuegeneric tradefree business phone numbers Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 2.00, with a high estimate of 8.00 and a low estimate of 0.50. The ...Stock Splits: Mergers & Acquisitions: Business Services/Equipment M&A Construction M&A General Contractors & Builders M&A Consumer Goods M&A Sporting Goods & Activities M&A Office Supplies M&A Food & Beverage M&A Beverages & Wineries M&A Cigarettes & Tobacco M&A Marijuana Stocks M&A Apparel Stores M&A Department Stores M&A … healthcare stockstaiwan semiconductor manufacturing news The Biden administration is pushing hard to promote electric vehicles (EVs). From a $7.5 billion pro barndominiums inside EXAS Stock 12 Months Forecast. $95.46. (50.43% Upside) Based on 14 Wall Street analysts offering 12 month price targets for Exact Sciences in the last 3 months. The average price target is $95.46 with a high forecast of $120.00 and a low forecast of $80.00. The average price target represents a 50.43% change from the last price of $63.46.NTLA Stock 12 Months Forecast. Based on 19 Wall Street analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $78.65 with a high forecast of $136.00 and a low forecast of $31.00. The average price target represents a 151.68% change from the last price of $31.25.Find real-time AVGO - Broadcom Inc stock quotes, company profile, news and forecasts from CNN Business. ... EPS forecast (this quarter) $10.95: Annual revenue (last year) $33.2B: Annual profit ...